Results 11 to 20 of about 655,167 (267)
Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland [PDF]
BMC Infectious Diseases, 2018 Background We describe the prevalence of invasive carbapenem-resistant Acinetobacter spp. isolated from 2005 to 2016 in different regions of Switzerland.
A. Ramette +2 more
doaj +2 more sources
Carbapenem-resistant and carbapenem use in Japan: an ecological study
Journal of International Medical Research, 2019 Objective This study focused on carbapenem resistance in Pseudomonas aeruginosa and examined potential ecological correlations with carbapenem use in Japan. Methods The proportion of carbapenem-resistant P.
Fumitaka Terahara, Hiroshi Nishiura
doaj +2 more sources
Carbapenem resistance in critically important human pathogens isolated from companion animals: a systematic literature review [PDF]
Osong Public Health and Research Perspectives, 2022 This study aimed to describe the presence and geographical distribution of Gram-negative bacteria considered critical on the priority list of antibiotic-resistant pathogens published by the World Health Organization, including carbapenem-resistant ...
Angie Alexandra Rincón-Real +1 more
doaj +1 more source
Carbapenem Resistance In Enterobacteriaceae [PDF]
Sohag Medical Journal, 2020 Carbapenem resistance is now a public health concern worldwide. Carbapenem is considered the last resort antimicrobial drug used for treatment of hospital care associated infection and community acquired infection that resistant to all other β-lactam drugs. There are a different mechanisms by which bacteria become resistant to carbapenem drug including
Radwa Farag +3 more
openaire +1 more source
Mechanisms of Action of Carbapenem Resistance
Antibiotics, 2022 Carbapenem antibiotics are the most effective antimicrobials for the treatment of infections caused by the most resistant bacteria. They belong to the category of β-lactams that include the penicillins, cephalosporins, monobactams and carbapenems. This class of antimicrobials has a broader spectrum of activity than most other beta-lactams antibiotics ...
Aurilio, Caterina +8 more
openaire +3 more sources
Carbapenem-resistant genes primer sets.
, 2023 BackgroundCarbapenem-resistant Enterobacteriaceae (CRE) and Extended-spectrum beta-lactamase (ESBL) production among Gram-negative Enterobacteriaceae is an increasing global challenge due to the high morbidity and mortality associated with their ...
Frank Twum Aboagye (17304867) +3 more
core +1 more source
Scientific Reports, 2023 Analyzing the influence of the bed allocation and utilization efficiency in healthcare institutions on the isolation proportion of Multidrug-resistant organisms (MDROs) to provide data to support prevention and control of MDROs.
Xing-Tian Wang +10 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2021 Antibiotic resistance represents a major global concern. The rapid spread of opportunistically pathogenic carbapenemase-encoding bacteria (CEB) requires clinicians, researchers, and policy-makers to swiftly find solutions to reduce transmission rates and
Claudio Neidhöfer +6 more
doaj +1 more source
Management of carbapenem-resistant Enterobacteriaceae infections [PDF]
Clinical Microbiology and Infection, 2019 Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp., and is associated with diverse molecular mechanisms. Carbapenem resistance is often associated with resistance
Durante-Mangoni, Emanuele +2 more
openaire +3 more sources
Brazilian Journal of Infectious Diseases, 2016 Background: Little is known about factors associated with carbapenem-resistant Klebsiella pneumoniae infections in pediatric patients, who are initally colonized with carbapenem-resistant Klebsiella pneumoniae. Materials and methods: A retrospective case–
Hacer Akturk +9 more
doaj +1 more source